Minoxidil Ameliorates Myelodysplastic Syndrome by Targeting Wnt4 While Sparing Normal Hematopoiesis
December 2025
in “
Cell Communication and Signaling
”
Studysummary This study discovered that minoxidil affects hematopoiesis by downregulating wnt4, leading to suppression of hematopoietic stem and progenitor cells and alleviating MDS-like symptoms in zebrafish and mice, with hematologic safety achieved at optimized doses.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on link.springer.com →